mechanism 2,668 words KG: microglia
Contents

Microglia-Neuron Metabolic Cross-Talk in Neurodegeneration

Mechanism Info
Namemicroglia
Key Genes/ProteinsABCA1, ABCA7, ABCG1, ABI3, ACAT1, ACC
Linked Hypotheses125 hypotheses

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (185)

Proteostasis Enhancement via APOE Chaperone Targeting
Score: 0.72
APOE Isoform Conversion Therapy
Score: 0.72
...
Score: 0.68
Astrocytic Connexin-43 Upregulation Enhances Neuroprotective
Score: 0.68
Complement C1QA Spatial Gradient in Cortical Layers
Score: 0.68
Excitatory Neuron Vulnerability via SLC17A7 Downregulation
Score: 0.67
Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain A
Score: 0.67
Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli
Score: 0.67
Multi-Modal CRISPR Platform for Simultaneous Editing and Mon
Score: 0.63
Restoring Neuroprotective Tryptophan Metabolism via Targeted
Score: 0.61
Complement-Mediated Synaptic Pruning Dysregulation
Score: 0.61
Epigenetic Memory Reprogramming for Alzheimer's Disease
Score: 0.61
LRP1-Dependent Tau Uptake Disruption
Score: 0.60
Glycosaminoglycan Template Disruption Approach
Score: 0.60
Brain Insulin Resistance with Glucose Transporter Dysfunctio
Score: 0.60
VCP-Mediated Autophagy Enhancement
Score: 0.59
TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.58
Synaptic Vesicle Tau Capture Inhibition
Score: 0.58
HSP90-Tau Disaggregation Complex Enhancement
Score: 0.57
HSP70 Co-chaperone DNAJB6 Universal Cross-Seeding Inhibitor
Score: 0.54
← Prevpg 9/10Next →

Related Analyses (30)

Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · completed
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived

Related Experiments (30)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Tau Co-Pathology in DLB Clinical Heterogeneity
clinical · proposed · Score: 0.40
s:** - Temporal analysis showing mitochondrial defects prece
falsification · proposed · Score: 0.40
DLB Treatment Response Biomarkers — Predicting Cholinesteras
clinical · proposed · Score: 0.40
Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy
validation · proposed · Score: 0.40

See Also (15)

Neuroimaging for Parkinsonian Syndromes (NCT03872102)
clinical · Pages share 27 hypotheses
China Neurodegeneration Epidemiology
disease · Pages share 139 hypotheses
Synaptic Biomarkers in Neurodegeneration
biomarker · Pages share 139 hypotheses
BEACoN Study - Biomarker Exploration in Aging, Cognitio
clinical · Pages share 139 hypotheses
Beta-Propeller Protein-Associated Neurodegeneration (BP
disease · Pages share 139 hypotheses

Knowledge Graph (12 edges)

VCP associated_with microglia
mBDNF associated_with microglia
microglia associated_with BDNF
EGFR expresses microglia
GRN associated_with microglia
BIN1 associated_with microglia
CLU associated_with microglia
GFP associated_with microglia
ABCA1 associated_with microglia
GDNF associated_with microglia

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.